Skip to main content
Premium Trial:

Request an Annual Quote

Power3, Mercy Women s Center Ink Breast Cancer Biomarker Deal

NEW YORK, Sept. 20 (GenomeWeb News) - Power3 Medical Products said today that it has signed an agreement to collaborate with Mercy Women's Center on the identification of protein biomarkers in blood serum that correlate to breast cancer.

 

Under this arrangement, Mercy Women's Center will provide Power3 with up to 600 blood serum samples from normal subjects and subjects with various stages of breast cancer. Additional terms of the deal were not disclosed.

 

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.